title: Efficacy of a strategy for discontinuing pre-emptive ganciclovir therapy after a negative cytomegalovirus antigenaemia test result in seropositive kidney transplant recipients.
authors: So-Youn
authors: SY
authors: Park
authors: Young Hoon
authors: YH
authors: Kim
authors: Duck Jong
authors: DJ
authors: Han
authors: Su-Kil
authors: SK
authors: Park
authors: Jung Sik
authors: JS
authors: Park
authors: Heungsup
authors: H
authors: Sung
authors: Hyun Jung
authors: HJ
authors: Park
authors: Sung-Han
authors: SH
authors: Kim
authors: Sang-Ho
authors: SH
authors: Choi
authors: Yang Soo
authors: YS
authors: Kim
authors: Jun Hee
authors: JH
authors: Woo
authors: Sang-Oh
authors: SO
authors: Lee
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage*; D018890:Chemoprevention / Q000379:methods*; D003587:Cytomegalovirus / Q000302:isolation & purification*; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D005260:Female; D015774:Ganciclovir / Q000008:administration & dosage*; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014180:Transplantation
chemical_list: D000998:Antiviral Agents; D015774:Ganciclovir